Reolysin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The oncolytic viruses that were discovered in the late of 19th century have been recently considered as an effective anti-cancer…
REOLYSIN® (pelareorep) is a proprietary isolate of the reovirus T3D (Type 3 Dearing) strain which is currently being tested in…
Trevor G Shepherd Cancer Research Laboratory Program, London Regional Cancer Program, 790 Commissioners Road East, Room A4-836…
Reovirus, also known under the tradename REOLYSIN®, is currently under clinical trial as an oncolytic agent. The specificity of…
This Phase II open-label single agent study was designed to characterize the o , us n ng s an v ra e ec s. s a ows rep ca on an…
Purpose:To determine the safety and feasibility of daily i.v. administration of wild-type oncolytic reovirus (type 3 Dearing) to…
Agomelatine, AGRO-100, AIDSVAX gp120 B/E, alfimeprase, aliskiren fumarate, ALVAC vCP1452, alvocidib hydrochloride, ambrisentan…